Nouveau Life Valuation
| NOUV Stock | USD 0.0001 0.0001 50.00% |
Nouveau Life seems to be fairly valued based on Macroaxis valuation methodology. Our model forecasts the value of Nouveau Life Pharmac from analyzing the firm fundamentals such as Price To Book of 22.72 X, current valuation of 722.68 K, and Return On Equity of -2.2 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Nouveau Life's price fluctuation is out of control at this time. Calculation of the real value of Nouveau Life Pharmac is based on 3 months time horizon. Increasing Nouveau Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Nouveau pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Nouveau Life Pharmaceuticals. Since Nouveau Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nouveau Pink Sheet. However, Nouveau Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 9.9E-5 | Hype 9.4E-5 | Naive 1.13E-4 |
The intrinsic value of Nouveau Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Nouveau Life's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Nouveau Life Pharmaceuticals helps investors to forecast how Nouveau pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nouveau Life more accurately as focusing exclusively on Nouveau Life's fundamentals will not take into account other important factors: Nouveau Life Total Value Analysis
Nouveau Life Pharmaceuticals is now anticipated to have valuation of 722.68 K with market capitalization of 484.8 K, debt of 0, and cash on hands of 1.1 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Nouveau Life fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
722.68 K | 484.8 K | 0 | 1.1 K |
Nouveau Life Asset Utilization
One of the ways to look at asset utilization of Nouveau is to check how much profit was generated for every dollar of assets it reports. Nouveau Life Pharmaceuticals secures a negative usage of assets of -0.2 %, losing $0.001983 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Nouveau Life Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.Nouveau Life Profitability Analysis
Net Loss for the year was (357.25 K) with profit before overhead, payroll, taxes, and interest of 0.About Nouveau Life Valuation
Our relative valuation model uses a comparative analysis of Nouveau Life. We calculate exposure to Nouveau Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Nouveau Life's related companies.Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in the development of nutraceuticals products. Nouveau Life Pharmaceuticals, Inc. operates as a subsidiary of EMG Marketing Solutions, Inc. Nouveau Life is traded on OTC Exchange in the United States.
8 Steps to conduct Nouveau Life's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Nouveau Life's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Nouveau Life's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Nouveau Life's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Nouveau Life's revenue streams: Identify Nouveau Life's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Nouveau Life's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Nouveau Life's growth potential: Evaluate Nouveau Life's management, business model, and growth potential.
- Determine Nouveau Life's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Nouveau Life's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Nouveau Life Growth Indicators
Investing in growth stocks can be very risky. If the company such as Nouveau Life does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Retained Earnings | -2.8 M |
Additional Tools for Nouveau Pink Sheet Analysis
When running Nouveau Life's price analysis, check to measure Nouveau Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nouveau Life is operating at the current time. Most of Nouveau Life's value examination focuses on studying past and present price action to predict the probability of Nouveau Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nouveau Life's price. Additionally, you may evaluate how the addition of Nouveau Life to your portfolios can decrease your overall portfolio volatility.